despit
consider
advanc
research
treatment
precis
relationship
inflamm
cardiovascular
cv
diseas
remain
incomplet
understood
therefor
understand
immunoinflammatori
process
underli
initi
progress
exacerb
mani
cardiovascular
diseas
prime
import
innat
immun
system
ancient
origin
well
conserv
across
speci
activ
occur
respons
pathogen
tissu
injuri
recent
studi
suggest
alter
ionic
balanc
product
noxiou
gaseou
mediat
link
immun
inflammatori
respons
alter
ion
channel
express
function
among
plausibl
candid
transient
receptor
potenti
trp
channel
function
polymod
sensor
scaffold
protein
involv
mani
physiolog
patholog
process
review
first
focu
relev
trp
channel
exogen
endogen
factor
relat
innat
immun
respons
transcript
factor
relat
sustain
inflammatori
statu
emerg
role
inflammasom
regul
innat
immun
possibl
connect
trp
channel
also
discuss
secondli
discuss
linkag
trp
channel
inflammatori
cv
diseas
viewpoint
inflamm
gener
sens
restrict
innat
immun
knowledg
may
serv
provid
new
insight
pathogenesi
variou
inflammatori
cv
diseas
novel
therapeut
strategi
past
two
decad
grow
attent
direct
pivot
role
immunoinflammatori
process
initi
progress
exacerb
mani
cardiovascular
diseas
includ
atherosclerosi
postinjuri
vascular
stenosi
myocardi
infarct
heart
failur
myocard
vascul
allograft
vasculopathi
view
origin
remark
paradigm
shift
made
ross
first
describ
bexcess
inflammatoryfibroprolif
respons
variou
form
insult
endothelium
smooth
muscl
arteri
walli
essenti
pathogenesi
atherosclerosi
paramount
evid
innat
adapt
immun
reaction
avidli
contribut
mani
patholog
chang
cardiovascular
system
involv
remodel
major
cellular
compon
cardiovascular
tissu
also
activ
immun
cell
migrat
accumul
therein
particular
note
solid
evid
rapidli
accumul
central
signific
binflammasom
serv
platform
mediat
mani
innat
immun
reaction
inflammasom
compos
pattern
recognit
receptor
apoptosisassoci
specklik
protein
contain
card
asc
cleav
inact
precursor
gener
major
inflammatori
cytokin
interleukin
il
interest
connect
pathogenand
nonpathogenderiv
celltox
signal
infect
tissu
damag
metabol
disord
dysfunct
state
cell
see
activ
inflammasom
thought
key
process
lead
chronic
inflammatori
autoinflammatori
diseas
yet
mechan
activ
still
remain
poorli
understood
howev
intrigu
suggest
activ
inflammasom
may
depend
crucial
alter
ionic
balanc
ca
k
cl
product
noxiou
gaseou
mediat
downstream
mediat
ro
first
glanc
besid
type
channel
transport
k
cl
ca
properti
strongli
reminisc
transient
receptor
potenti
trp
channel
review
paper
aim
promot
understand
rapidli
develop
field
ie
emerg
signific
trp
channel
immunoinflammatori
mechan
cardiovascular
cv
system
particular
interest
innat
immun
end
first
part
focu
exogen
endogen
factor
relat
innat
immun
sustain
statu
ie
chronic
inflamm
possibl
connect
trp
channel
activ
emerg
role
autophagi
regul
innat
immun
possibl
connect
trp
channel
also
discuss
last
part
discuss
linkag
trp
channel
cv
inflammatori
diseas
rather
viewpoint
inflamm
gener
sens
restrict
innat
immun
avail
inform
field
still
greatli
limit
reader
interest
anoth
import
topic
connect
adapt
immunopathophysiolog
variou
ca
mechan
advis
consult
excel
review
publish
elsewher
innat
immun
system
ancient
origin
well
conserv
across
speci
plant
invertebr
vertebr
system
defend
frontlin
microbi
infect
tissu
damag
consist
environment
sensor
cellular
signal
cascad
product
antimicrobi
peptid
recognit
pathogenassoci
molecular
pattern
pamp
nonpathogenassoci
dangeror
damageassoci
molecular
pattern
damp
first
step
activ
innat
immun
respons
fulfil
via
specif
receptor
call
pattern
recognit
receptor
prr
prr
famili
compris
membranebound
tolllik
receptor
tlr
ctype
lectin
receptor
retinoid
acidinduc
gene
rig
receptor
nucleotidebind
oligomer
domain
nod
receptorlik
receptor
nlr
tlr
shown
express
ubiquit
cell
constitut
resid
cv
system
cardiomyocyt
endotheli
cell
macrophargesmonocyt
dendrit
cell
respect
activ
prr
pamp
damp
known
subsequ
activ
inflammasom
wherebi
promot
product
highli
proinflammatori
cytokin
varieti
inflammatori
factor
suggest
activ
inflammasom
includ
direct
indirect
signal
recognit
factor
viru
bacteri
toxin
particl
matter
autoantibodi
product
releas
cell
dysfunct
although
biochem
morpholog
evid
coexpress
ppr
recent
studi
suggest
trp
channel
may
function
act
cofactor
pampdampmedi
signal
multitud
ligand
endogen
exogen
origin
avail
evid
suggest
connect
tlr
trp
channel
occur
directli
lp
diacylglycerol
dag
ro
pkc
trp
channel
famili
nonselect
cation
channel
function
polymod
signal
detector
involv
varieti
bodi
function
diseas
trp
channel
membran
protein
six
put
transmembran
segment
pore
region
differ
mammalian
trp
channel
identifi
classifi
six
subfamili
basi
sequenc
homolog
canon
classic
trpc
vanilloid
trpv
melastatin
trpm
polycystin
trpp
mucolipin
trpml
ankyrin
trpa
differ
trp
channel
show
distinct
cation
select
gate
mechan
activ
wide
array
physic
chemic
stimuli
regul
trp
channel
occur
transcript
translat
posttransl
level
frequent
depend
ionic
balanc
microbi
ligand
cytokin
reactiv
oxygen
speci
ro
inde
inflammatori
transcript
factor
nuclear
factorkappa
b
signal
transduc
activ
transcript
hypoxiainduc
factor
hif
link
ro
elev
intracellular
ca
concentr
featur
render
trp
channel
potenti
effect
modul
inflamm
follow
discuss
trp
channel
connect
respect
factor
mechan
activatemodul
inflamm
innat
immun
factor
affect
innat
immun
respons
via
trp
channel
see
fig
viral
bacteri
infect
logic
candid
environment
trigger
immun
reaction
associ
trp
channeldepend
signal
inflammasom
activ
upon
recognit
microbi
pathogen
tlr
serv
germlineencod
prr
play
central
role
host
cell
recognit
respons
howev
tlrdepend
signal
link
trp
channel
unclear
recent
sever
studi
past
year
reveal
intrigu
connect
tlr
trp
channel
one
studi
report
hemolyt
streptococc
infect
affect
express
level
least
seven
trp
member
ie
anoth
studi
show
play
function
role
host
defens
gramneg
bacteria
upon
infect
mice
exhibit
decreas
surviv
sever
lung
injuri
system
bacteri
dissemin
furthermor
sirna
silenc
result
decreas
ca
entri
reduc
proinflammatori
cytokin
product
lower
bacteri
clearanc
importantli
bacteriummedi
activ
coupl
cascad
signal
ca
entri
trigger
activ
facilit
ntermin
kinas
jnk
activ
augment
proinflammatori
respons
lead
tissu
damag
eventu
mortal
find
favor
view
activ
requir
host
defens
bacteri
infect
signal
pathway
excess
activ
may
lead
exacerb
inflamm
similar
inoppositedirect
involv
ca
entri
tlrmediat
inflamm
demonstr
microglia
macrophag
c
e
n
r
c
r
n
l
l
n
c
u
l
e
w
h
h
e
l
n
h
mesocestoid
corti
known
human
infect
relat
helminth
cestod
taenia
solium
immunosuppress
rather
inflammatori
respons
asymptomat
phase
infect
experi
use
intracellular
ca
elev
ro
may
induc
inflammasom
activ
moreov
dysfunct
trp
channel
mitochondria
lysosom
also
activ
inflammasom
note
appropri
oper
autophagi
essenti
suppress
activ
would
prevent
product
inflammatori
cytokin
trp
channelmedi
ca
influx
regul
inflammasom
activ
fulli
understood
quit
conceiv
would
play
key
role
innat
immun
respons
question
mark
denot
hypothet
pathway
requir
proof
solubl
parasit
factor
mesocestoidesinfect
mice
show
suppress
storeoper
ca
entri
factor
consequ
inhibit
jnk
mapk
pathway
like
respons
immunosuppress
novel
immunosuppress
mechan
appear
therapeut
use
prevent
initi
tlrdepend
inflammatori
respons
via
suppress
activ
cultur
macrophag
howev
degrad
induc
caspas
activ
inflammasom
activ
lipopolysaccharid
lp
found
increas
secret
neg
regul
occur
independ
cleavag
cell
death
thu
like
reflect
distinct
mechan
describ
consist
higher
secret
observ
sepsi
model
mice
made
intraperiton
lp
inject
although
alway
caveat
relev
knockout
studi
compensatori
express
homolog
type
molecul
might
affect
downstream
signal
similar
argument
may
also
hold
trp
knockout
model
see
result
collect
impli
presenc
multipl
signal
pathway
involv
regul
tlrmediat
inflamm
detail
analys
necessari
understand
manipul
activ
could
util
immunemodulatori
intervent
inflamm
addit
evid
link
trp
member
tlrmediat
signal
airway
smooth
muscl
asm
cell
exposur
proinflammatori
cytokin
tnf
alpha
mixtur
allergen
ovalbumin
hous
dust
mite
alternaria
aspergillu
extract
caus
acut
chronic
inflamm
inflammatori
respons
involv
least
part
increas
secret
brainderiv
neurotroph
factor
bdnf
manner
depend
ca
entri
endotheli
cell
ec
endotoxin
lp
induc
patholog
vascular
leakag
occur
interact
signal
ca
entri
caus
increas
endotheli
permeabl
via
activ
nonmuscl
myosin
light
chain
kinas
mylk
genet
delet
render
mice
resist
endotoxininduc
barrier
dysfunct
inflamm
protect
sepsisinduc
lethal
causal
relat
lpsinduc
endotheli
cell
death
via
intracellular
na
overload
pharmacolog
inhibit
activ
glibenclamid
found
attenu
consequ
suggest
therapeut
potenti
endotoxin
shock
intracellular
concentr
ca
ca
elev
serv
key
regul
endotoxininduc
endotheli
fibrosi
endotheli
mesenchym
transit
channel
also
implic
lpsinduc
endotheli
cell
migrat
via
pathway
mice
show
compromis
innat
immun
listeria
monocytogen
infect
allow
uncontrol
replic
bacteria
significantli
reduc
product
consist
find
cecal
ligat
punctur
clp
induc
mous
sepsi
model
genet
disrupt
found
caus
impair
host
defens
lead
increas
mortal
associ
increas
bacteri
burden
organ
injuri
system
inflamm
interestingli
find
appear
reflect
fail
upregul
heme
oxgenas
ho
macrophag
normal
induc
ca
influx
essenti
bacteri
clearanc
recent
year
potenti
benefit
activ
recogn
abat
inflammatori
respons
exampl
helicobact
pyloriposit
patient
genet
polymorph
c
suggest
one
pathophysiolog
factor
function
dyspepsia
murin
sepsi
model
genet
pharmacolog
disrupt
affect
mortal
blood
bacteria
clearanc
cytokin
respons
pattern
may
vari
accord
sepsisinduc
event
method
disrupt
salivari
gland
polyinosinicpolycytidyl
acid
lp
activ
via
activ
degrad
phosphoryl
releas
highli
proinflammatori
cytokin
capsaicin
inhibit
process
interact
pathway
wherebi
potenti
allevi
inflamm
salivari
gland
inde
healthi
human
subject
well
patient
capsaicin
suggest
therapeut
potenti
alon
combin
nonsteroid
antiinflammatori
drug
mous
clp
model
capsaicin
shown
reliev
damag
impact
sepsi
activ
msu
cholesterol
ambient
particl
matter
msu
uric
acid
crystal
monosodium
urat
msu
emerg
import
factor
gouti
arthriti
immun
regul
simpl
crystallin
structur
appear
activ
innat
host
defens
mechan
multipl
way
trigger
robust
inflamm
immun
reaction
msu
enter
cell
msu
trigger
inflammasom
activ
activ
mechan
respons
still
elus
number
report
suggest
sensori
trp
channel
may
contribut
activ
process
howev
interest
hypothet
link
reli
intracellular
ca
measur
whether
msu
crystal
directli
activ
shown
consid
msu
crystal
act
oxid
stress
facilit
ro
product
may
activ
via
ro
product
nevertheless
fact
mediat
msu
crystalinduc
inflamm
pain
experiment
model
strongli
support
undoubt
role
inflammatori
mediat
high
serum
level
cholesterol
hypercholesterolemia
risk
factor
cv
diseas
promot
inflammatori
respons
includ
tlr
signal
inflammasom
activ
product
monocyt
neutrophil
bone
marrow
spleen
cholesterol
also
shown
signific
impact
sever
differ
type
trp
channel
activ
cellular
cholesterol
affect
arteri
reactiv
endotheliumdenud
caudal
arteri
cholesterol
deplet
treatment
attenu
vasoconstrict
parallel
reduct
storeoper
ca
entri
via
similarli
cholesterolmedi
activ
observ
trp
channel
express
hek
cell
applic
cholesterol
enhanc
activ
prostat
cancer
cell
endogen
express
cholesterolmedi
activ
import
initi
andor
progress
cancer
vascular
smooth
muscl
cell
vsmc
express
detect
mrna
protein
level
freshli
isol
aorta
constitut
activ
channel
posit
modul
contractil
respons
independ
ltype
calcium
channel
elev
cholesterol
suppress
channel
activ
result
collect
suggest
appropri
level
cholesterol
may
requisit
normal
contractil
arteri
excess
level
may
lead
cv
diseas
well
makeup
microenviron
propensit
cancer
develop
fibrillar
peptid
main
pathogen
factor
alzheim
diseas
ad
report
activ
contribut
oxid
stressinduc
striatal
cell
death
rat
striatum
activ
thought
occur
direct
indirect
pathway
accumul
increas
vascular
oxid
stress
via
mitochondri
dysfunct
result
sequenti
occurr
dna
damag
polyadpribos
polymeras
activ
adpribos
product
ec
lead
dysfunct
via
intracellular
ca
overload
result
cerebrovascular
dysfunct
may
acceler
ad
pathogenesi
reduc
cerebr
blood
glucos
suppli
increas
suscept
vascular
insuffici
promot
accumul
oxid
stresssensit
trp
channel
also
implic
damag
cell
type
includ
glia
smooth
muscl
cell
ec
exposur
ambient
particul
matter
pm
signific
risk
factor
increas
respiratori
cardiopulmonari
morbid
mortal
mechan
underli
remain
larg
unknown
addit
implic
sensori
nerv
airway
hypersensit
inflamm
involv
environment
noxiou
stimuli
evid
pm
act
proinflammatori
agent
endothelium
increas
vascular
permeabl
vitro
vivo
via
ro
gener
suggest
possibl
oxid
stresssensit
trp
channel
may
involv
pmmediat
pathophysiolog
inde
implic
cellular
tissu
damag
caus
pmmediat
oxid
stress
associ
diesel
exhaust
wood
smoke
concentr
ambient
particl
autophagi
highli
evolutionarili
conserv
catabol
process
degrad
recycl
cytoplasm
content
via
lysosom
rout
reus
downstream
metabol
becom
increasingli
clear
insuffici
autophagi
import
pathogen
mechan
inflammatori
diseas
recent
possibl
link
autophagi
defici
increas
inflammasom
activ
suggest
mechan
propos
includ
follow
causal
sequenc
cellular
event
ineffici
mitophagi
accumul
damag
mitochondria
increas
ro
product
rosmedi
inflammasom
activ
occur
either
directli
indirectli
via
dna
damag
secondari
inflammatori
signal
autophagi
defici
also
reduc
effici
lysosom
degrad
therebi
facilit
accumul
intralysosom
lipid
cholesterol
crystal
lead
lysosom
membran
destabil
lysosom
leakag
inflammasom
activ
similar
consequ
autophagi
defici
expect
ineffici
lysosom
degrad
damag
organel
protein
therefor
normal
function
autophagi
system
indispens
keep
cell
healthi
import
player
endosom
sort
transport
process
late
endocytot
phase
specif
format
late
endosomelysosom
hybrid
vesicl
word
role
channel
control
deliveri
cellular
materi
lysosom
essenti
process
autophagi
alter
activ
implic
lysosom
dysfunct
impair
autophagi
associ
adlink
mutat
patholog
state
disrupt
lysosom
acidif
due
defect
vesicular
atpas
activ
thought
primarili
respons
lysosom
autophagi
deficit
concurr
abnorm
cytosol
ca
elev
occur
via
facilit
ca
efflux
channel
howev
correct
abnorm
ca
homeostasi
alon
suffici
restor
normal
lysosom
proteolyt
autophag
activ
thu
suggest
may
play
permiss
role
process
regard
may
deserv
mention
human
mutat
gene
encod
channel
caus
neurodegen
disord
mucolipidosi
type
iv
mliv
novel
ca
channel
play
crucial
role
regul
cargo
traffick
along
endosom
autophagosom
matur
pathway
infect
bladder
epitheli
cell
bec
trigger
nonlyt
expuls
bacteria
power
cellautonom
defens
strategi
rapidli
reduc
infecti
burden
lysosom
channel
capabl
sens
uropathogen
escherichia
colimedi
lysosom
neutral
turn
releas
ca
therebi
trigger
lysosom
exocytosi
expel
bacteria
fulllength
form
channel
short
splice
variant
consist
n
terminu
first
two
transmembran
segment
lack
pore
domain
express
system
coexpress
suppress
oxidantinduc
ca
entri
subsequ
cell
death
presum
neg
physic
interact
although
pathophysiolog
signific
unclear
recent
studi
reveal
interest
connect
short
variant
autophagi
mitochondri
homeostasi
dynam
regul
process
autophagymitophagi
mitochondri
biogenesi
compar
tumor
cell
express
isoform
abundantli
express
show
accumul
damag
mitochondri
dna
increas
level
unremov
heat
shock
protein
mitochondri
protein
translocas
outer
membran
mitochondria
result
interpret
suggest
oxidantinduc
ca
entri
mediat
may
crucial
maintain
normal
autophagi
mitophagi
activ
oxid
stress
induc
pleiotrop
respons
rang
cell
surviv
death
recent
studi
given
interest
explan
differenti
cell
fate
ie
involv
distinct
poli
adpribos
polymeras
parp
isoform
distinct
cellular
local
channel
parp
enzym
produc
poli
adpribos
conjunct
poli
adpribos
glyocohydoras
capabl
activ
channel
via
immedi
convers
poli
adpribos
monomer
adpribos
moder
oxid
stress
condit
mm
h
plasma
membran
control
activ
lead
phosphoryl
sapkjnk
camp
respons
elementbind
protein
creb
ultim
induc
autophagi
therebi
allow
cell
surviv
contrast
high
oxid
stress
mm
h
trigger
late
autophagi
step
activ
lead
cell
death
activ
lysosom
channel
trp
channel
may
link
persist
activ
inflammasom
see
fig
earli
inflammatori
respons
absolut
essenti
elimin
pathogen
termin
process
equal
import
step
failur
control
inflamm
lead
immunopatholog
includ
cv
diseas
organ
dysfunct
time
lead
fibrot
cancer
transform
chronic
inflamm
three
aspect
progress
inflamm
respect
inflammasom
activ
first
bprimingsign
enhanc
gene
express
inflammasom
compon
second
ignal
promot
assembl
inflammasom
compon
last
bamplificationsign
drive
feedback
signal
amplif
loop
inflammasom
activ
promot
matur
secret
two
potent
inflammatori
cytokin
inflammasom
respond
pathogen
also
varieti
bdanger
signalsr
eleas
inflam
tissu
includ
cytokin
tissu
degrad
product
etc
lead
format
danger
posit
feedback
loop
continu
exacerb
inflammasom
respons
patholog
condit
activ
transcript
factor
eg
nuclear
factor
activ
cell
nfat
inflammatori
cytokin
appear
crucial
amplif
loop
inflammasom
therefor
suppress
amplif
loop
key
import
effect
elimin
infect
stop
acut
inflamm
andor
restor
homeostat
regul
concentr
extracellular
intracellular
ca
increas
site
infect
inflamm
immun
cell
activ
shown
increas
extracellular
calcium
could
act
danger
signal
amplifi
inflamm
via
activ
g
proteincoupl
calcium
sens
receptorphosphatidylinositolca
inflammasom
signal
pathway
therefor
ca
influx
may
serv
import
control
point
inflammasom
activ
need
tightli
regul
host
order
avoid
excess
product
cytokin
overt
cell
death
moreov
proinflammatori
transcript
factor
particular
ca
depend
one
may
play
central
role
control
section
attempt
summar
connect
inflammatori
transcript
factor
trp
channel
consist
famili
transcript
factor
play
critic
role
inflamm
immun
cell
prolifer
differenti
surviv
one
factor
known
activ
elev
ca
sever
paper
link
ca
permeabl
trp
channel
inflammatori
reaction
suppress
ca
entri
inhibit
activ
associ
immunosuppress
mechan
helminth
infect
pharmacolog
inhibit
channel
suggest
involv
lpsinduc
ec
migrat
via
signal
endotoxininduc
lung
injuri
involv
activ
manner
depend
ca
entri
therapeut
potenti
target
valid
decoy
treatment
number
inflammatori
cv
diseas
includ
myocard
poststent
coronari
restenosi
coronari
hypertoph
prolifer
dual
role
transduc
signal
cytoplasm
function
transcript
factor
nucleu
activ
extrins
pathway
ie
environment
factor
ultraviolet
uv
radiat
chemic
carcinogen
infect
stress
cigarett
smoke
growth
factor
cytokin
tolllik
adrenerg
nicotin
receptor
respect
persist
activ
mediat
cell
prolifer
surviv
invas
inflammasom
activ
sever
studi
suggest
trp
channel
may
regul
activ
receptorinduc
phosphoryl
cellular
janu
kinas
cjun
regul
ca
influx
could
caus
persist
inflamm
result
chronic
inflamm
global
tissu
chang
injuri
ca
transport
activ
close
associ
activ
andor
notch
signal
pathway
turn
induc
ischem
neuron
cell
death
metastat
transform
breast
cancer
cell
prolifer
migrat
invas
glioma
stem
cell
fingerprint
sustain
chronic
inflamm
albeit
littl
evid
tempt
specul
constitut
ca
permeat
activ
channel
might
effect
drive
via
ca
depend
activ
feedback
cycl
persist
activ
inflammasom
toward
chronic
inflamm
differ
line
evid
suggest
activ
signal
pathway
therebi
facilit
express
antiinflammatori
neuropeptid
hint
uniqu
protect
role
inflamm
rare
seen
type
trp
channel
hif
transcript
factor
respond
chang
avail
oxygen
cellular
environ
howev
recent
research
suggest
certain
patholog
set
hif
receptor
trp
fig
possibl
link
trp
channel
persist
inflammasom
activ
inflamm
mediat
signal
transduct
inflammationrel
receptor
stresssens
trp
channel
transcript
factor
breceptorpathway
activ
via
alter
intern
extern
environment
factor
affect
cell
includ
abnorm
upregul
persist
activ
receptor
eg
cytokin
receptor
growth
factor
receptor
tolllik
receptor
increas
kinas
activ
excess
ro
product
intracellular
ca
perturb
btrppathway
also
activ
alter
intern
extern
environment
factor
suscept
regul
function
express
level
importantli
pathway
may
intersect
modul
sinc
mani
environment
factor
associ
inflamm
physic
chemic
cellstress
stimuli
besid
involv
prolifer
surviv
migrat
differenti
transcript
factor
induc
express
mani
proinflammatori
cytokin
inflammatori
mediat
importantli
receptor
mani
cytokin
chemokin
mediat
activ
inflammatori
transcript
factor
therebi
form
autocrin
paracrin
feedback
loop
would
result
continu
amplif
promot
inflammatori
reaction
lead
chronic
inflamm
induct
normoxia
like
caus
seriou
consequ
encompass
chronic
inflammatori
compon
chronic
inflamm
selfperpetu
process
may
continu
distort
cellular
microenviron
result
aberrantli
activ
transcript
factor
consequ
alter
growth
factor
chemokin
cytokin
redox
balanc
occur
within
cellular
milieu
turn
provid
axi
growth
surviv
need
de
novo
develop
cancer
metastasi
addit
recent
studi
suggest
pathway
import
sustain
inflammasom
activ
consid
trp
channel
serv
import
ca
entri
rout
associ
cellular
stress
possibl
abnorm
trp
channel
activ
would
damag
intracellular
microorganel
disturb
redox
balanc
fact
mani
report
found
linkag
trp
channel
eg
calcineurinnfat
signal
play
pivot
role
transcript
cytokin
gene
gene
critic
cellmedi
adapt
immun
respons
howev
later
studi
identifi
ubiquit
role
organ
system
exampl
establish
role
nfat
cv
system
hub
mediat
hypertroph
signal
heart
mechan
neurohormon
stress
activ
calcineurinnfat
signal
induc
promin
patholog
hypertrophi
member
trpc
subfamili
implic
activ
step
signal
stresssens
ca
permeat
channel
blood
vessel
therapeut
benefit
immunosuppress
cyclosporin
known
transplant
vasculopathi
part
causal
relat
inhibit
calcineurinnfat
signal
ec
diabet
mice
pharmacolog
inhibit
nfat
reduc
atherosclerot
lesion
inhibit
cytokin
releas
adhes
molecul
express
albeit
scanti
inform
involv
trpc
member
suggest
inflammatori
respons
renal
podocyt
injuri
structur
function
remodel
myocardi
infarct
via
activ
calcineurinnfat
signal
howev
littl
evid
yet
obtain
directli
link
trp
channel
chronic
inflammatori
diseas
eg
atherosclerosi
signal
pathway
mani
cv
diseas
tightli
associ
inflammatori
immun
respons
pathogenesi
includ
wide
rang
vascular
diseas
endotoxin
shock
acut
vascul
atherosclerosi
postop
stenosi
allograft
vasculopathi
cardiac
diseas
cardiac
hypertrophi
dilat
cardiomyopathi
myocardi
infarct
ischemiareperfus
injuri
myocard
sever
autoimmun
diseas
cv
system
final
section
review
briefli
overview
present
known
cv
diseas
term
trp
channel
physiolog
pathophysiolog
see
also
tabl
atherosclerosi
progress
inflammatori
diseas
disintegr
structur
function
blood
vessel
lipid
deposit
activ
innateadapt
immun
reaction
good
evid
suggest
trp
channel
involv
respect
stage
atherosclerosi
describ
stagebystag
manner
main
initi
factor
atherosclerosi
oxid
lowdens
lipoprotein
oxldl
affect
endotheli
surfac
therebi
induc
ec
dysfunct
inflammatori
componentsel
viru
bacteria
toxin
toxic
nutrient
metabolit
ambient
particl
autoantibodi
heat
shock
protein
see
also
also
promot
atherosclerosi
among
trp
channel
express
cv
two
report
suggest
proatherogen
potenti
channel
report
cardiovascular
risk
factor
lysophosphatidylcholin
lpc
facilit
transloc
cell
membran
caus
rapid
ca
influx
ec
turn
induc
extern
therebi
allow
sustain
ca
influx
complex
cascad
activ
caus
inhibit
ec
migrat
essenti
heal
atherosclerot
arteri
endotheli
express
microrna
reduc
aortic
intima
atherogen
apo
mice
oxldltreat
human
ec
wherea
overexpress
induc
ec
apoptosi
act
neg
regul
activ
allow
ca
influx
activ
mitochondri
apoptot
pathway
associ
atherosclerosi
thu
abnorm
activ
induc
apoptot
ec
death
applic
may
abl
reduc
atherosclerot
lesion
result
provid
albeit
indirect
evid
support
nontrivi
role
progress
atherosclerosi
site
injuri
ec
allow
entri
monocyt
lymphocyt
vessel
wall
earli
stage
process
adhes
monocyt
endotheli
surfac
support
increas
intracellular
ca
concentr
ec
monocyt
contact
ec
ca
influx
ec
activ
strengthen
adher
monocyt
pharmacolog
inhibit
reduc
number
adher
monocyt
activ
ca
influx
like
enabl
strong
adhes
stenosi
system
lupu
erythematosu
linkag
analysi
data
infantil
hypertroph
pylor
stenosi
autoimmun
autoantibodi
nd
hypertens
diabet
nd
ec
endotheli
cell
smc
smooth
muscl
cell
oxldl
oxid
lowdens
lipoprotein
tumor
necrosi
factor
ir
ischemia
reperfus
nd
data
ang
ii
angiotensin
ii
mir
microrna
adp
adenosin
diphosph
poli
adpribos
dcm
dilat
cardiomyopathi
ro
reactiv
oxygen
speci
mi
myocardi
infarct
bdnf
brainderiv
neurotroph
factor
trkb
tropomyosin
receptor
kinas
b
proteaseactiv
nfat
nuclear
factor
activ
cell
monocyt
ec
similar
context
ca
influx
implic
atpinduc
express
vascular
cell
adhes
critic
recruit
monocyt
ec
injuri
monocyt
transmigr
across
damag
endothelium
enter
intim
layer
vessel
wall
thu
reduc
monocyt
infiltr
thought
one
power
strategi
attenu
progress
atherosclerosi
major
atherogen
agent
lpc
induc
strong
chemotaxi
monocyt
appear
requir
ca
influx
pharmacolog
character
lpcactiv
ca
permeabl
current
strongli
suggest
activ
trpc
necessari
optim
chemotax
activ
regard
two
trp
channel
could
good
molecular
target
antiatherosclerot
therapi
monocyt
migrat
intima
differenti
macrophag
uptak
oxldl
lipidladen
macrophag
known
foam
cell
although
main
foam
cell
deriv
macrophag
vsmc
also
transform
foam
cell
interestingli
activ
capsaicin
imped
transform
oxldltreat
vsmc
foam
cell
rescu
otherwis
impair
autophagi
oxldl
moreov
activ
protect
macrophag
oxldlinduc
lipid
accumul
inflamm
result
indic
activ
capsaicin
anoth
effect
strategi
inhibit
atherosclerosi
transform
foam
cell
start
produc
inflammatori
cytokin
releas
inflammatori
cytokin
trigger
transform
vsmc
gain
abil
migrat
medial
intim
layer
inflammatori
respons
make
atherosclerot
plaqu
necrosi
apoptosi
complet
clinic
pictur
atherosclerosi
cultur
macrophag
lpsinduc
product
cytokin
shown
depend
ca
influx
thu
late
stage
atherosclerosi
target
may
anoth
novel
strategi
suppress
inflammatori
cytokin
product
thu
format
atherosclerot
lesion
bypass
surgeri
angioplasti
stent
often
caus
vascular
injuri
injur
vsmc
undergo
transform
quiescent
contractil
invas
prolif
state
phenotyp
switch
import
process
recov
vascular
contractil
also
part
caus
occlus
vascular
diseas
includ
atherosclerosi
advers
respons
accompani
neointim
hyperplasia
sever
line
evid
suggest
excess
constitut
activ
rosinduc
activ
vsmc
involv
neointim
hyperplasia
induc
vascular
cuff
injuri
rat
mous
model
respect
chang
accompani
enhanc
cell
cycl
activ
inhibit
specif
antibodi
rais
third
extracellular
loop
channel
antibodi
similar
increas
express
also
observ
intim
layer
human
vein
graft
sampl
thu
channel
may
novel
therapeut
target
occlus
vascular
diseas
cardiomyocyt
ca
transient
convey
inform
contract
gene
transcript
chang
cytoplasm
ca
cardiomyocyt
control
varieti
ion
channel
na
ca
exchang
ca
pump
ca
bind
protein
sever
recent
studi
use
anim
model
implic
trp
channel
develop
hypertrophi
shown
hypertroph
agonist
upregul
express
channel
cardiac
myocyt
lead
activ
ca
ro
calmodulincalcineurinnfat
pathway
eventu
result
cardiac
hypertrophi
hypertroph
chang
patholog
process
basic
involv
inflammatori
reaction
ultim
reduc
cardiac
function
increas
mortal
experiment
anim
recent
studi
ad
new
connect
trp
channel
cardiomyopathi
patient
cardiomyopathi
well
genet
chemic
induc
anim
model
typic
show
ventricular
dilat
fibrosi
sever
compromis
heart
function
express
found
concentr
ventricular
sarcolemma
specif
abrog
activ
either
overexpress
aminotermin
domain
amino
acid
treatment
chemic
inhibitor
amelior
patholog
chang
contractil
function
heart
improv
surviv
affect
anim
sinc
excess
activ
associ
increas
product
ro
phosphoryl
ca
calmodulindepend
protein
kinas
ii
camk
ii
particip
inflammatori
process
strongli
suggest
patholog
chang
thu
target
may
becom
new
clinic
option
treat
cardiomyopathyassoci
heart
failur
addit
recent
gene
invalid
studi
show
activ
may
prerequisit
prevent
develop
eccentr
ventricular
hypertrophi
heart
inde
shown
neg
regul
angiotensin
iiinduc
cardiac
hypertrophi
owe
membran
depolar
abil
wherebi
magnitud
storeoper
ca
entri
activ
calcineurinnfat
hypertroph
pathway
neg
control
correl
find
inflamm
howev
unclear
sinc
immunohistolog
examin
reveal
obviou
sign
fibrosi
hypertrophi
rather
hyperplasia
smaller
size
cardiomyocyt
compar
normal
one
infarct
myocardium
necrot
cardiomyocyt
releas
danger
signal
activ
intens
inflammatori
respons
complex
cellular
process
associ
injuri
repair
remodel
infarct
region
activ
mi
period
anim
model
human
patient
plasma
level
brainderiv
neurotroph
factor
bdnf
found
elev
along
tropomyosinrel
kinas
b
trkb
downstream
effector
channel
bdnf
treatment
infarct
size
markedli
reduc
cardiac
contractil
significantli
restor
seem
associ
decreas
apoptot
respons
cardiomyocyt
sinc
benefici
effect
bdnf
revers
pharmacolog
function
inhibit
channel
channel
like
play
protect
role
detriment
cardiac
remodel
mi
puzzl
contrast
howev
adenovirusmedi
overexpress
report
induc
hypertroph
respons
via
nfatmedi
signal
adult
felin
cardiomyocyt
accompani
reduct
contractil
catecholamin
respons
due
increas
spontan
ca
leak
sr
studi
mice
treat
mi
procedur
show
similarli
enhanc
express
ca
channel
activ
along
induct
hypertroph
gene
two
line
evid
interpret
indic
benefit
block
trpc
channel
improv
postmi
structur
remodel
dysfunct
matter
investig
differ
experiment
set
would
make
dispar
consequ
trpc
channel
activ
postmi
recoveri
sharp
contrast
protect
role
dilat
cardiomyopathi
see
delet
gene
mice
rather
improv
surviv
cardiac
reserv
experiment
induc
ischem
heart
failur
addit
sever
line
evid
support
amelior
role
myocardi
infarct
found
atherosclerosi
reperfus
ischem
myocardium
essenti
rescu
death
howev
reperfus
caus
addit
myocardi
injuri
term
bischemiareperfus
ir
injuri
ir
injuri
heart
occur
innat
immun
respons
involv
tlr
trifdepend
pathway
activ
induc
releas
proinflammatori
immunomodulatori
cytokin
moreov
oxid
stressinduc
acut
inflammatori
respons
implic
develop
ir
injuri
two
conflict
report
link
channel
ir
injuri
one
studi
suggest
activ
neutrophil
channel
ro
exacerb
myocardi
ir
injuri
upregul
express
endotheli
adhes
molecul
result
stronger
adhes
neutrophil
coronari
ec
surfac
neutrophil
accumul
myocardium
key
process
induc
myocardi
injuri
thu
specif
inhibit
neutrophil
activ
may
serv
effect
mean
mitig
exacerb
myocardi
infarct
howev
strike
contrast
view
independ
studi
propos
oppos
complex
hypothesi
accord
find
studi
genet
delet
exacerb
extent
myocardi
dysfunct
ir
injuri
via
increas
gener
upregul
nadph
oxidas
decreas
scaveng
capac
downregul
superoxid
anion
disulmutas
ro
point
author
discrep
two
studi
may
reflect
small
essenti
differ
experiment
design
well
use
global
knockout
mice
differ
exontarget
invalid
strategi
case
almost
undoubt
channel
among
central
player
immunoinflammatori
reaction
cardiovascular
diseas
thu
promis
therapeut
target
review
summar
current
knowledg
link
inflamm
trp
channel
attempt
provid
new
insight
pathogenesi
variou
inflammatori
cv
diseas
refer
tabl
addit
describ
evid
dysregul
alter
express
trp
channel
close
associ
inflammasom
activ
pathogenesi
cv
diseas
major
tent
conclus
drawn
review
write
follow
may
promis
therapeut
target
subacut
chronic
stage
cv
diseas
ie
remodel
prolifer
presum
via
inhibit
persist
inflammasom
activ
well
aberr
regul
cytokin
product
transcript
factor
activ
case
ischemiareperfus
molecul
sensingtransduc
oxid
stress
appear
contributori
initi
inflamm
wherein
channel
plausibl
candid
although
role
oxid
stresssensit
channel
underestim
final
dietari
capsaicin
appear
act
sensori
nerv
eg
clp
sepsi
model
vsmc
eg
atherosclerosi
activ
may
broad
relev
improv
cv
disord
antiinflammatori
action
current
research
immunopathophysiolog
trp
channel
still
infant
stage
thu
strongli
anticip
extens
investig
greatli
improv
yet
prematur
understand
pave
way
develop
new
effect
therapi
inflammatori
cv
diseas
